New Treatment Methods in Multiple Myeloma-Reference-Cited by-同舟云学术

New Treatment Methods in Multiple Myeloma

Published:2017-06-01 Issue:2 Volume:2 Page:144-149
ISSN:2501-8132
Container-title:Journal of Interdisciplinary Medicine
language:en
Short-container-title:

Author:

Jakab Szende¹²,Lázár Erzsébet¹²,Benedek István¹²,Köpeczi Judit Beáta¹,Pakucs Annamária¹,Benedek István¹²

Affiliation:

1. Clinic of Hematology and Bone Marrow Transplantation Unit , Tîrgu Mureș , Romania

2. University of Medicine and Pharmacy , Tîrgu Mureș , Romania

Abstract

Abstract Multiple myeloma accounts for 10% of the hematologic malignancies and is characterized by a single clone of plasma cells producing a monoclonal protein. The aim of this review is to summarize the current treatment methods of multiple myeloma. In the last 15 years, the incidence of myeloma has increased in patients younger than 65 years, thus treatment became even more important in order to obtain a long lasting remission or plateau phase. The treatment of this disease is complex and focuses not only on increasing the patients’ survival, but also improving their quality of life.

Publisher

Walter de Gruyter GmbH

Reference38 articles.

1. 1. Provan D, Baglin T, Dokal I, et al. Oxford Handbook of Clinical Haematology, 4th ed. Oxford University Press, 2015; p. 336-361.

2. 2. Palumbo A, Cerrato C. Diagnosis and therapy of multiple myeloma. Korean J Intern Med. 2013;28:263-273.

3. 3. Bergsage D, Sprague C, Austin C, et al. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma: IV. L-Phenylalanine mustard (NC-8806). Cancer Chemotherapy Rep. 1962;21:87.

4. 4. Rosignol L, Oriol A, Terulel A, et al. Superiority of bortezomib, thalidomide and dexamethasone as induction pre-transplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study. Blood. 2012;120:1589-1596.

5. 5. Moreau P, Facon T, Attal M, et al. Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma. Final analysis of the IFM95-02 randomized trial. Blood. 2002;99:731-735.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Therapies;Update on Multiple Myeloma;2019-02-20